Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient

American Journal on Addictions

Volumn 21, Issue 3, 2012, Pages 287-288

  Peglow, Stephanie ^a   Buchner, Jessica ^a   Briscoe, Gregory ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Hampton VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; BENZATROPINE; CANNABINOID; GABAPENTIN; HYDROXYZINE;

ADULT; CASE REPORT; CLINICAL FEATURE; HOSPITAL READMISSION; HUMAN; LETTER; MALE; MEDICAL HISTORY; POSTTRAUMATIC STRESS DISORDER; PSYCHOSIS; SUBSTANCE ABUSE;

CANNABINOIDS; HUMANS; MALE; MIDDLE AGED; PSYCHOSES, SUBSTANCE-INDUCED; STREET DRUGS;

EID: 84859879293     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00222.x     Document Type: Letter

References (9)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Understanding the 'Spice' Phenomenon. Lisbon: EMCDDA; 2009. Available at: http://www.emcdda.Europa.eu/publications/thematic-papers/spice. Accessed January 10, 2011; Archived at Website http://www.webcitation.org/5wNZasIsa.
2. Every-Palmer S.Warning: Legal synthetic cannabinoids-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction. 2010;105:1859-1861.
3. Vearrier D, Osterhoudt KC. A teenager with agitaiton: Higher than she should have climbed. Pediatr Emerg Care. 2010;26:462-465.
4. Müller H, Sperling W, Köhrmann M, et al. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. 2010;118: 309-310.
5. Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, et al. Withdrawal phenomena and dependence syndrome after the consumption of 'Spice Gold'. Dtsh Artzebl Int. 2009;106:464-467.
6. Weissman A, Milne GM, Melvin LS. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J Pharmacol Exp Ther. 1982;223:516-523. (Pubitemid 12005757)
7. Melvin LS, Johnson MR, Harbart CA, et al. A cannabinoid derived prototypical analgesic. J Med Chem. 1984;27:67-71. (Pubitemid 14176379)
8. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic of affective mental health outcomes: A systematic review. Lancet. 2007;370:319-328. (Pubitemid 47094993)
9. Muller-Vahl KR, Emrick HM. Cannabis and schizophrenia: Towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother. 2008;8:1037-1048.